Device Trial Radar · NCT05830968
Safety and Efficacy of Radio Frequency for the Treatment of Mild to Severe Inflammatory Acne
Last checked: Nov 19, 2026Latest source record: Nov 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
46
Actual
Start
May 1, 2023
Primary completion
May 1, 2025
Study completion May 1, 2026
Sponsor
- Lead sponsor
- InMode MD Ltd.Public (INMD)
- Sponsor type
- Industry
- First posted
- Apr 26, 2023
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 16 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The aim of this trial is to evaluate the safety and efficacy of the InMode RF Pro System with the Morpheus8 face tip (24 pins) applicator for the treatment of mild, moderate and severe, facial acne vulgaris
Conditions
- Inflammatory Acne Vulgaris
Interventions
Morpheus8 Applicator Radiofrequency deviceDevice
Eligible subjects will receive 2 treatments with the Morpheus8 according to the study protocol. All participants will return for 2 follow up visits: 4 weeks (1M FU) and 12 weeks (3M FU) after the 2nd treatment. Total expected study duration is \~6 months, depending on subject recruitment rate.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percent of responderTime frame: Month 3
Locations
4 sites in 1 country. Site status is shown where the registry gives one.
Avant Dermatology Aesthetics
Oro Valley, Arizona
AboutSkin Research, LLC
Greenwood Village, Colorado
UnionDerm
New York, New York
1 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.